- Home
- PBYI vs TEAF Comparison
PBYI vs TEAF Comparison
Compare PBYI & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- TEAF
- Stock Information
- Founded
- PBYI 2010
- TEAF 2017
- Country
- PBYI United States
- TEAF United States
- Employees
- PBYI N/A
- TEAF N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- PBYI Health Care
- TEAF Finance
- Exchange
- PBYI Nasdaq
- TEAF Nasdaq
- Market Cap
- PBYI 176.1M
- TEAF 165.2M
- IPO Year
- PBYI N/A
- TEAF N/A
- Fundamental
- Price
- PBYI $2.59
- TEAF $12.94
- Analyst Decision
- PBYI Strong Buy
- TEAF
- Analyst Count
- PBYI 1
- TEAF 0
- Target Price
- PBYI $7.00
- TEAF N/A
- AVG Volume (30 Days)
- PBYI 345.1K
- TEAF 56.1K
- Earning Date
- PBYI 10-31-2024
- TEAF 01-01-0001
- Dividend Yield
- PBYI N/A
- TEAF 9.20%
- EPS Growth
- PBYI N/A
- TEAF N/A
- EPS
- PBYI 0.18
- TEAF N/A
- Revenue
- PBYI $219,143,000.00
- TEAF N/A
- Revenue This Year
- PBYI N/A
- TEAF N/A
- Revenue Next Year
- PBYI N/A
- TEAF N/A
- P/E Ratio
- PBYI $13.90
- TEAF N/A
- Revenue Growth
- PBYI N/A
- TEAF N/A
- 52 Week Low
- PBYI $2.13
- TEAF $11.11
- 52 Week High
- PBYI $7.73
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- PBYI 45.60
- TEAF 74.78
- Support Level
- PBYI $2.23
- TEAF $12.18
- Resistance Level
- PBYI $2.42
- TEAF $12.37
- Average True Range (ATR)
- PBYI 0.15
- TEAF 0.12
- MACD
- PBYI 0.05
- TEAF 0.06
- Stochastic Oscillator
- PBYI 76.60
- TEAF 92.33
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.